secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001104659-25-034689
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics receives Nasdaq deficiency notice for stockholders' equity shortfall
--------------------------------------------------------------------------------

- Stockholders' equity of ($3,876,738) as of Dec 31, 2024, well below Nasdaq's $2.5M minimum.
- Company also failed alternative compliance standards for market value or net income.
- Must submit compliance plan by May 26, 2025; Nasdaq may grant extension to Oct 8, 2025.
- Company intends to submit a plan, but no assurance of acceptance or regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/0001104659-25-034689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925034689/tm2512284d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-034689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer